Farouc Jaffer, MD
Interventional Cardiology · Boston, MANPI 1083605547
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Boston Scientific at 38.4% of the total. Reporting peaked in 2019 at $76,212 and has fallen 59.6% since, to $30,803 in 2025. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $772.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$82K
- Abbott$40K
- Medtronic$36K
- Siemens Medical Solutions USA, Inc.$13K
- Biotronik Inc.$11K
- Philips North America LLC$5K
- plus $26K from 15 others
Across 78 payments — averaging $8800.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$208K
- Arrow International, Inc.$169K
- Heartflow, Inc.$119K
- Boston Scientific$84K
- Shockwave Medical, Inc$83K
- Canon Medical Systems Corporation$21K
- plus $4K from 1 others
What the payments were for
- Consulting fees$98,60646%
- Speaking & faculty fees$67,70032%
- Travel & lodging$34,85716%
- Food & beverage$12,0276%
- Gifts$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 86 | $81,868 |
| Abbott | 38 | $40,493 |
| Medtronic | 68 | $35,826 |
| Siemens Medical Solutions USA, Inc. | 14 | $13,345 |
| Biotronik Inc. | 20 | $10,840 |
| Philips North America LLC | 14 | $5,347 |
| Cleerly, Inc. | 7 | $5,038 |
| Shockwave Medical, Inc | 6 | $4,956 |
| Magenta Medical Inc | 4 | $4,955 |
| Abiomed | 4 | $3,700 |
| Novartis | 2 | $2,147 |
| Asahi Intecc USA, Inc. | 1 | $2,000 |
| Mercator Medsystems, Inc. | 1 | $1,000 |
| Terumo Medical Corporation | 2 | $700 |
| Teleflex LLC | 3 | $411 |
| Reflow Medical Inc | 1 | $177 |
| Edwards Lifesciences | 1 | $136 |
| Cordis US CORP. | 1 | $123 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Chiesi USA, Inc. | 1 | $75 |
| Cathworks, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience V coronary stent system$36,597
- GENERAL VASCULAR ACCESS$32,499
- CROSSBOSS$18,462
- GENERAL - THERAPIES$13,316
- SYMPLICITY G3$7,538
- GENERAL BALLOONS$7,500
- (9520) IGT Devices Undivided$5,076
- Astron; Pulsar; AstronPulsar$4,857
- Orsiro$4,857
- Pulsar$4,857
- PK Papyrus$4,857
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$4,812
- Passeo$4,151
- GENERAL - STRUCTURAL HEART$4,133
- Impella$3,700
- Hi-Torque Pilot guide wire$3,000
- SYNERGY$2,250
- LEQVIO$2,147
- ASAHI PTCA Guide Wire$2,000
- AVVIGO Guidance System$1,338
How this compares
$213,265 in reported general payments places this provider in the 90th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ranolazine ErRanolazine | 42 | $2,298 |
| Metoprolol Succinate | 25 | $114 |
| Amlodipine Besylate | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boston
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Suzanne BaronBoston$274K
- Joseph GarasicBoston$152K
- Pinak ShahBoston$147K
- Douglas DrachmanBoston$132K
- Hector Tamez AguilarBoston$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.